Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Decreasing longitudinal use of glucocorticosteroids in multiple sclerosis.

Ellenberger D, Eichstädt K, Flachenecker P, Friede T, Haas J, Kleinschnitz C, Pöhlau D, Rienhoff O, Stahmann A, Zettl UK, Rommer PS.

Mult Scler Relat Disord. 2018 Jul 24;25:173-174. doi: 10.1016/j.msard.2018.07.040. [Epub ahead of print] No abstract available.

PMID:
30096682
2.

Applying the 2017 McDonald diagnostic criteria for multiple sclerosis.

Rommer PS, Zettl UK.

Lancet Neurol. 2018 Jun;17(6):497-498. doi: 10.1016/S1474-4422(18)30161-3. No abstract available.

PMID:
29778357
3.

Coping behavior in multiple sclerosis-complementary and alternative medicine: A cross-sectional study.

Rommer PS, König N, Sühnel A, Zettl UK.

CNS Neurosci Ther. 2018 Apr 10. doi: 10.1111/cns.12857. [Epub ahead of print]

4.

Managing the side effects of multiple sclerosis therapy: pharmacotherapy options for patients.

Rommer PS, Zettl UK.

Expert Opin Pharmacother. 2018 Apr;19(5):483-498. doi: 10.1080/14656566.2018.1446944. Epub 2018 Mar 12. Review.

PMID:
29528247
5.

Interferon β-1a and β-1b for patients with multiple sclerosis: updates to current knowledge.

Zettl UK, Hecker M, Aktas O, Wagner T, Rommer PS.

Expert Rev Clin Immunol. 2018 Feb;14(2):137-153. doi: 10.1080/1744666X.2018.1426462. Epub 2018 Jan 23.

PMID:
29318902
6.

Manifestations of neurological symptoms and thromboembolism in adults with MTHFR-deficiency.

Rommer PS, Zschocke J, Fowler B, Födinger M, Konstantopoulou V, Möslinger D, Stögmann E, Suess E, Baumgartner M, Auff E, Sunder-Plassmann G.

J Neurol Sci. 2017 Dec 15;383:123-127. doi: 10.1016/j.jns.2017.10.035. Epub 2017 Nov 6.

PMID:
29246599
7.

Treatment of the First Acute Relapse Following Therapeutic Plasma Exchange in Formerly Glucocorticosteroid-Unresponsive Multiple Sclerosis Patients-A Multicenter Study to Evaluate Glucocorticosteroid Responsiveness.

Ehler J, Blechinger S, Rommer PS, Koball S, Mitzner S, Hartung HP, Leutmezer F, Sauer M, Zettl UK.

Int J Mol Sci. 2017 Aug 11;18(8). pii: E1749. doi: 10.3390/ijms18081749.

8.

Lowered Levels of Carbonyl Proteins after Vitamin B Supplementation in Patients with Mild Cognitive Impairment and Alzheimer's Disease.

Rommer PS, Fuchs D, Leblhuber F, Schroth R, Greilberger M, Tafeit E, Greilberger J.

Neurodegener Dis. 2016;16(3-4):284-9. doi: 10.1159/000441565. Epub 2015 Nov 21.

PMID:
26587902
9.

7-Tesla MRI demonstrates absence of structural lesions in patients with vestibular paroxysmia.

Rommer PS, Wiest G, Kronnerwetter C, Zach H, Loader B, Elwischger K, Trattnig S.

Front Neuroanat. 2015 Jun 9;9:81. doi: 10.3389/fnana.2015.00081. eCollection 2015.

10.

Neuromagnetic cortical activation during initiation of optokinetic nystagmus: an MEG pilot study.

Rommer PS, Beisteiner R, Elwischger K, Auff E, Wiest G.

Audiol Neurootol. 2015;20(3):189-94. doi: 10.1159/000375114. Epub 2015 Apr 22.

PMID:
25924627
11.

Patients characteristics influencing the longitudinal utilization of steroids in multiple sclerosis--an observational study.

Rommer PS, Buckow K, Ellenberger D, Friede T, Pitschnau-Michel D, Fuge J, Stüve O, Zettl UK; German Multiple Sclerosis Registry of the German National MS Society.

Eur J Clin Invest. 2015 Jun;45(6):587-93. doi: 10.1111/eci.12450. Epub 2015 May 9.

PMID:
25868705
12.

Elevated levels of carbonyl proteins in cerebrospinal fluid of patients with neurodegenerative diseases.

Rommer PS, Greilberger J, Salhofer-Polanyi S, Auff E, Leutmezer F, Herwig R.

Tohoku J Exp Med. 2014 Dec;234(4):313-7. doi: 10.1620/tjem.234.313.

13.

Effect of methylprednisolone on mammalian neuronal networks in vitro.

Wittstock M, Rommer PS, Schiffmann F, Jügelt K, Stüwe S, Benecke R, Schiffmann D, Zettl UK.

Cell Mol Neurobiol. 2015 Jan;35(1):111-4. doi: 10.1007/s10571-014-0117-y. Epub 2014 Oct 5.

PMID:
25283186
14.

Contribution of spinal cord biopsy to diagnosis of aquaporin-4 antibody positive neuromyelitis optica spectrum disorder.

Ringelstein M, Metz I, Ruprecht K, Koch A, Rappold J, Ingwersen J, Mathys C, Jarius S, Brück W, Hartung HP, Paul F, Aktas O; Neuromyelitis Optica Study Group (NEMOS).

Mult Scler. 2014 Jun;20(7):882-8. doi: 10.1177/1352458513510981. Epub 2013 Nov 5.

15.

Management of secondary progressive multiple sclerosis: prophylactic treatment-past, present, and future aspects.

Rommer PS, Stüve O.

Curr Treat Options Neurol. 2013 Jun;15(3):241-58. doi: 10.1007/s11940-013-0233-x.

PMID:
23609781
16.

Monoclonal antibodies in the treatment of neuroimmunological diseases.

Rommer PS, Patejdl R, Zettl UK.

Curr Pharm Des. 2012;18(29):4498-507. Review.

PMID:
22612751
17.

Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients.

Jarius S, Ruprecht K, Wildemann B, Kuempfel T, Ringelstein M, Geis C, Kleiter I, Kleinschnitz C, Berthele A, Brettschneider J, Hellwig K, Hemmer B, Linker RA, Lauda F, Mayer CA, Tumani H, Melms A, Trebst C, Stangel M, Marziniak M, Hoffmann F, Schippling S, Faiss JH, Neuhaus O, Ettrich B, Zentner C, Guthke K, Hofstadt-van Oy U, Reuss R, Pellkofer H, Ziemann U, Kern P, Wandinger KP, Bergh FT, Boettcher T, Langel S, Liebetrau M, Rommer PS, Niehaus S, Münch C, Winkelmann A, Zettl U UK, Metz I, Veauthier C, Sieb JP, Wilke C, Hartung HP, Aktas O, Paul F.

J Neuroinflammation. 2012 Jan 19;9:14. doi: 10.1186/1742-2094-9-14.

18.

Rituximab for secondary progressive multiple sclerosis: a case series.

Rommer PS, Patejdl R, Winkelmann A, Benecke R, Zettl UK.

CNS Drugs. 2011 Jul;25(7):607-13. doi: 10.2165/11589390-000000000-00000.

PMID:
21699272
19.

Cerebrospinal fluid antibodies to aquaporin-4 in neuromyelitis optica and related disorders: frequency, origin, and diagnostic relevance.

Jarius S, Franciotta D, Paul F, Ruprecht K, Bergamaschi R, Rommer PS, Reuss R, Probst C, Kristoferitsch W, Wandinger KP, Wildemann B.

J Neuroinflammation. 2010 Sep 8;7:52. doi: 10.1186/1742-2094-7-52.

20.

A woman with acute myelopathy in pregnancy: case outcome.

Reuss R, Rommer PS, Brück W, Paul F, Bolz M, Jarius S, Boettcher T, Grossmann A, Bock A, Zipp F, Benecke R, Zettl UK.

BMJ. 2009 Dec 10;339:b4026. No abstract available.

PMID:
20007656

Supplemental Content

Loading ...
Support Center